Mutations that inactivate the p53 tumoursuppressor-protein network occur in most human cancers and, consequently, the roles and regulation of p53 activity in tumour formation are the topic of intense research. Inherited germline mutations in the p53 gene promote cancer in mice and humans, and p53 loss interacts with various mutant genes to transform normal cells into tumour cells. p53 is a stressresponse protein, which suppresses tumour formation by triggering programmed cell death (apoptosis); by activating cell-cycle checkpoints that prevent damaged cells from proliferating; or by promoting senescence (permanent cellcycle arrest). Thus, inacti va tion of p53 facilitates the expansion of aberrant cells and leads to rampant genome instability. Five papers [1] [2] [3] [4] [5] in this issue describe how disruption of the p53 network also enhances the production of induced pluripotent stem (iPS) cells*. Although these observations catapult p53 into the centre of stem-cell research, time will tell whether they represent a promise or a warning.
iPS cells were first produced three years ago 6 by the enforced expression of genes encoding four transcription factors (c-Myc, Klf4, Sox2 and Oct4) in mouse fibroblast cells. , also promotes cellular senescence directly to limit both processes. The Ink4a/Arf locus (not shown), which encodes p19
Arf and p16
Ink4a
, is silenced during iPS reprogramming 2, 4 . *This article and the papers concerned [1] [2] [3] [4] [5] were previously published online.
recipient genome -techniques that could lead to cancer. Subsequently, in a flurry of activity, researchers identified ways to produce iPS cells without c-myc 7 , devoid of viral integration 8 , or using only proteins for reprogramming 9 . Indeed, the 'factorology' of iPS-cell production is all the rage, reminiscent of the early days of cancer-gene discovery, when researchers raced to identify the first genes and gene combinations that could convert normal cells to an immortal, cancerous state.
The new studies [1] [2] [3] [4] [5] add to the frenzy by decisively showing that inactivation of p53 markedly increases the efficiency of iPS-cell production. Furthermore, Kawamura et al. 3 (page 1140) show that p53 deficiency simplifies iPS generation by enabling production of iPS cells with only two factors, Oct4 and Sox2. Also, three groups [1] [2] [3] show that p53-deficient iPS cells can give rise to adult tissues when implanted into mouse embryos.
As p53 inactivation promotes genome instability and cancer, the risks of producing iPS cells that lack this essential tumour suppressor may outweigh its benefits. In line with this, Marión et al. 5 (page 1149) reveal that p53-deficient iPS cells are genomically unstable and are not 'fit' enough to efficiently produce mice. And even when mice can be generated partly from iPS cells as in the work by Hong and colleagues 1 (page 1132), they eventually develop tumours. In addressing such safety concerns, Utikal et al. 4 (page 1145) demonstrate that transient, rather than permanent, inhibition of p53 also enhances reprogramming efficiency. Still, for p53-suppressed iPS cells to be used therapeutically, it must be shown that the reconstituted tissues function normally and remain tumour free. Moreover, next-generation sequencing and other genomic technologies must be used to demonstrate that these cells do not acquire deleterious mutations.
Beyond its therapeutic implications, this body of work 1-5 presents overlapping but contrasting views of the mechanism by which p53 limits reprogramming and, in particular, is inconclusive as to whether interaction between the p53 network and reprogramming pathways is direct or indirect. Li et al. 2 (page 1136) show that the Ink4a/Arf locus, which encodes a cellcycle inhibitor (p16 Ink4a ) and an indirect p53 activator (p19 Arf ), is silenced during iPS reprogramming. They argue that this silencing occurs early in reprogramming, implying a direct effect of the reprogramming factors on this locus. There is, however, no consensus about the timing of downregulation of Ink4a/Arf expression during reprogramming 2, 4 . Other observations 3, 4 point to an indirect interaction between reprogramming factors and p53 through activation of a p53-mediated stress response (for instance, apoptosis or senescence). Accordingly, three groups 1-3 provide evidence that one key p53 effector in the process is the cell-cycle inhibitor p21. Indeed, Gil and colleagues 10 suggest that senescence represents the primary barrier to reprogramming. It is well established that cells with an intact p53 network are prone to senescence in culture 11 , and perhaps this alone explains why normal cells are more difficult to reprogram. Accordingly, Utikal et al. 4 show that spontaneously immortalized cells exhibiting unrestricted growth in culture, with or without obvious p53 impairment, are readily reprogrammed into iPS cells.
At face value, the results of these studies are reminiscent of work 12 , published 25 years ago, showing that loss of p53 facilitates cellular immortalization -a state of endless self-renewal that is one of the first steps towards cancer. And more recently, p53 has been implicated as a factor that limits the self-renewal capacity of certain stem cells 13, 14 . Even in the iPS field, previous work had shown that the SV40 T antigen -an immortalizing oncogenic protein that disables p53 -or transient inhibition of p53 using small interfering RNAs, enhance reprogramming efficiency 15, 16 . The current studies substantially extend and expand on these findings, and provide new platforms for more effectively studying reprogramming.
Just as the race to find new reprogramming factors is reminiscent of the hunt for co operating oncogenes, the remarkable similarities between the reprogramming processes and oncogenic transformation may provide insights into cancer (Fig. 1) . Indeed, both processes require specific combinations of collaborating genes that can produce a less differentiated cell able to proliferate and self-renew indefinitely. All four factors initially shown to reprogram cells are overexpressed in at least some types of tumour, and at least two of them -c-myc and Klf4 -are established oncogenes. Now we find that p53 -a tumour suppressor whose loss greatly increases the efficiency of oncogene cooperation in transforming normal cells to tumour cells 17 -affects reprogramming similarly. Notably, a gold-standard assay for the formation of iPS cells is in fact a tumorigenesis assay that measures their ability to form germ-cell tumours following transplantation into mice.
If the processes that lead to the production of iPS cells and tumours overlap, one wonders whether so-called cancer stem cells -cells capable of self-renewal that are considered essential for the propagation of some tumour types -might initially arise through a reprogramming-like mechanism. Moreover, not all of the factors required to trigger reprogramming of cells to iPS cells are necessary for their maintenance 8, 9 . If cancer arises through reprogramming-like processes, then perhaps many of the oncogenes that initiate tumour formation might be dispensable for tumour progression and, hence, be poor targets for new cancer When it was first discovered in 1995, the planet 51 Pegasi b astounded scientists with its 4.3-day orbital period. This placed the Jupitersized planet at around 5% of the Earth-Sun distance from its host star (0.05 au), a sweltering location where no planet had been expected to exist. But now with almost 375 extrasolar planets discovered to date, and nearly 20% of them located within 0.05 au of their parent stars, a discovery of another 'hot Jupiter' is no longer as exciting as it once was. On page 1098 of this issue, however, Hellier et al. 1 report the discovery of WASP-18b, a hot Jupiter (Fig. 1) that is sure to generate some buzz: the predicted remaining lifetime of the planet is less than a thousandth of the age of its host star, far shorter than that for any other known planet.
WASP-18b, the eighteenth planet discovered by Britain's Wide Angle Search for Planets project 2 , is only the second planet found with an orbital period of less than a day. Proximity to the host star, as well as the planet's large mass (10.3 times that of Jupiter), lead to strong tidal interactions between the two bodies, which elongate both of them along the line joining their centres. If the bodies spin as well, the tidal bulges can misalign, causing torques that couple their spins to their orbital angular momentum.
For a planet orbiting a star, the tides raised on the smaller object act swiftly to reduce its spin until one face is locked towards the star. The planet's initially elongated orbit also rapidly becomes circularized by these tides. By contrast, tides raised on the star usually act more slowly, and can either pull the planetary orbit inward (if the planet orbits faster than the star spins) or push it outward (if the stellar spin is faster). WASP-18b should be spiralling inward towards the star, and it is so close and
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Evidence that the most recently discovered extrasolar planet is virtually at the end of its life is a surprise. The odds of that are very low -similar to drawing two consecutive red aces from a well-shuffled deck of cards. 
